Davis Capital Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$446 Hold
8
– – ﹤0.01% 654
2026
Q2
$440 Buy
+8
New +$327 ﹤0.01% 637

Other funds holding TGTX

Davis Capital Management's TGTX Position: Q3 2026 in Review

Davis Capital Management held its TG Therapeutics (TGTX) position steady in Q3 2026 at 8 shares worth $446. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Davis Capital Management first reported a position in TGTX in Q2 2026 and has held it in 2 quarters since. 449 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Davis Capital Management held 8 shares of TG Therapeutics worth $446 as of Q3 2026.
  • Davis Capital Management left its TG Therapeutics share count unchanged in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #654 holding.
  • Davis Capital Management first reported a position in TG Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 449 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.